Product Name | MF | CAS | Details |
---|
SARS-CoV-2-IN-20 | C24H30N2O2 | 1260244-33-4 | Details |
SK3 Channel-IN-1 | C25H49NO | 2396571-04-1 | Details |
Anticancer agent 37 | C19H19N3O3S | 905783-28-0 | Details |
AChE/BChE-IN-9 | C20H19N3O4 | 2761542-55-4 | Details |
Anticancer agent 57 | C20H21Cl2NO2 | 2408017-71-8 | Details |
KDM5B-IN-3 | C19H25ClN4O2 | 1385101-10-9 | Details |
ASK1-IN-3 | C18H18N8O2 | 2426705-19-1 | Details |
EGFR-IN-51 | C21H15N3O2S | 2418549-32-1 | Details |
Z164597606 | C20H19N3O4 | 1050587-57-9 | Details |
NSC381467 | C20H16O7 | 1033006-96-0 | Details |
LSD1-IN-14 | C21H24FN5 | 2698340-11-1 | Details |
PPARγ agonist 3 | C24H23N3O | 2011801-48-0 | Details |
ATG7-IN-2 | C11H16N6O7S | 2226227-75-2 | Details |
ATG7-IN-3 | C11H16N6O5S2 | 2226229-76-9 | Details |
11β-HSD1-IN-6 | C21H19ClN4O | 1303515-33-4 | Details |
PPARγ agonist 7 | C20H30O6 | 2569295-93-6 | Details |
CB1-IN-2 | C17H19Cl2N5O | 2527805-39-4 | Details |
Anti-inflammatory agent 8 | C18H15N5OS2 | 1103920-19-9 | Details |
Aldose reductase-IN-6 | C20H16N4O2S | 2470019-41-9 | Details |
5-HT7 receptor ligand 1 | C21H23N7 | 2758571-64-9 | Details |
S07-2010 | C19H21N3O3S | 1223194-71-5 | Details |
VEGFR-2-IN-23 | C22H15N5O2 | 2411174-53-1 | Details |
ANO1-IN-2 | C16H14ClN3O2S2 | 637314-12-6 | Details |
Tubulin polymerization-IN-10 | C18H21NO6S | 2238784-19-3 | Details |
HPK1-IN-18 | C24H24N4 | 2403598-42-3 | Details |
TNIK-IN-4 | C20H16FN3O3 | 2754266-04-9 | Details |
DNA-PK-IN-2 | C20H23N5O3 | 2665720-22-7 | Details |
TGFβ-IN-2 | C22H22N2O4 | 2387678-02-4 | Details |
EV-A71-IN-1 | C21H15N5S | 2413648-96-9 | Details |
DPP-4-IN-1 | C19H19ClN6 | 2215027-46-4 | Details |
Nampt-IN-7 | C20H21N5O3 | 1223378-42-4 | Details |
Tyrosinase-IN-5 | C18H13N3O6 | 2525175-90-8 | Details |
TP0480066 | C18H14FN3O5 | 2245693-15-4 | Details |
HBV-IN-21 | C17H17FN4OS2 | 2460957-52-0 | Details |
TOPK-p38/JNK-IN-1 | C17H15F3N2O4 | 2745108-35-2 | Details |
Myt1-IN-2 | C18H16N6O2S | 2719748-43-1 | Details |
IMMH001 | C23H28N2O3 | 1418093-75-0 | Details |
AAK1-IN-4 | C20H28N4O3 | 1815612-79-3 | Details |
Plasma kallikrein-IN-3 | C20H23N5O2 | 1357950-47-0 | Details |
Antitumor agent-38 | C22H24N2O4 | 2744193-34-6 | Details |
HDAC-IN-42 | C20H15NO7 | 2454024-18-9 | Details |
Autophagy inducer 3 | C24H43NO2 | 2691054-63-2 | Details |
Tyrosinase-IN-3 | C21H23NO5 | 2409081-40-7 | Details |
Antibacterial agent 106 | C20H24N6S | 2459657-11-3 | Details |
5-HT2A receptor agonist-2 | C20H21ClN2O3 | 528525-37-3 | Details |
ERK5-IN-4 | C16H11Cl2FN4O2 | 1888305-17-6 | Details |
CXCR4 antagonist 5 | C21H30N6 | 2304749-86-6 | Details |
Antileishmanial agent-9 | C23H26O4 | 2477608-91-4 | Details |
ATR-IN-15 | C19H22N8O | 2756665-52-6 | Details |
Antitubercular agent-24 | C18H19N3O2S2 | 1845719-43-8 | Details |
(S)-Cdc7-IN-18 | C19H21N5OS | 2562329-13-7 | Details |
c-ABL-IN-3 | C17H11F3N4O3 | 2626934-64-1 | Details |
3-(3-Phenoxybenzyl)amino-β-carboline | C24H19N3O | 1327080-54-5 | Details |
PKC-IN-4 | C21H25N5S | 2636771-29-2 | Details |
Polyketide synthase 13-IN-2 | C22H21NO5 | 2219338-48-2 | Details |
CSF1R-IN-13 | C21H20N4O3 | 2361556-61-6 | Details |
S07-2005 (racemic) | C20H23NO6 | 1826337-40-9 | Details |
Tubulin/HDAC-IN-1 | C21H18N4O3 | 2413587-26-3 | Details |
Cdc7-IN-18 | C19H21N5OS | 2562329-14-8 | Details |
NHE3-IN-3 | C16H16Cl2N2O2S | 543734-50-5 | Details |
NMDA receptor antagonist 5 | C19H16BrNO2 | 2415998-36-4 | Details |
Trk-IN-20 | C22H18F2N4 | 2460924-63-2 | Details |
PKM2 activator 3 | C15H11ClF2N2O3S | 1346113-84-5 | Details |
hCAI/II-IN-4 | C15H15N3O5S2 | 2480284-01-1 | Details |
Antifungal agent 32 | C25H28N2O | 1809167-48-3 | Details |
Mt KARI-IN-4 | C13H8FN5O3S2 | 2413974-53-3 | Details |
Anticancer agent 47 | C19H14N2O4S | 2461795-23-1 | Details |
BuChE-IN-6 | C21H26N4O2 | 2003213-07-6 | Details |
Antiparasitic agent-5 | C20H16ClN3O3 | 2494276-55-8 | Details |
Gü1303 | C20H22N4O3 | 1043922-53-7 | Details |
Influenza A virus-IN-4 | C19H28N4O4 | 2390067-58-8 | Details |
SARS-CoV-2-IN-17 | C19H19F3N2O3 | 2761911-44-6 | Details |
FGFR-IN-7 | C16H21ClF2N4O2 | 2488764-17-4 | Details |
ATR-IN-16 | C19H25N7O | 2756589-62-3 | Details |
A1AR antagonist 4 | C23H25N3O2 | 1031993-35-7 | Details |
Anti-inflammatory agent 22 | C22H16O6 | 2721484-76-8 | Details |
CXCR4 antagonist 6 | C21H30N6 | 2304750-68-1 | Details |
Tubulin polymerization-IN-13 | C20H21NO6 | 2426665-56-5 | Details |
Mt KARI-IN-2 | C14H11N5O4S2 | 2413974-52-2 | Details |
FAK-IN-8 | C15H9Cl2N3O2S | 1374959-91-7 | Details |
RBM10-8 | C17H36NO5P | 2407372-42-1 | Details |
Falcipain-2/3-IN-2 | C21H23N3O4 | 946209-23-0 | Details |
ATR-IN-19 | C18H19N7OS | 2648989-61-9 | Details |
S1P1 agonist 4 | C24H31NO3 | 1883345-11-6 | Details |
HIF-2α-IN-5 | C15H12F4O3S2 | 2388500-66-9 | Details |
DPP-4 inhibitor 3 | C19H22N6O2 | 2402735-14-0 | Details |
HSV-1/HSV-2-IN-2 | C17H14ClFN4OS | 2490468-39-6 | Details |
DMX-129 | C19H17FN8 | 1623123-95-4 | Details |
ASIC-IN-1 | C23H25N3O2 | 308088-10-0 | Details |
GLP-1R modulator C5 | C24H21NO3 | 421578-93-0 | Details |
Neuraminidase-IN-5 | C19H11NO7 | 2473524-63-7 | Details |
DHFR-IN-4 | C18H21N5O2S | 2820126-49-4 | Details |
NPR-C activator 1 | C18H24N6O3 | 2768328-61-4 | Details |
D18 | C21H28N6 | 2230218-36-5 | Details |
IDO1/TDO-IN-1 | C21H16O6 | 2379527-72-5 | Details |
5-HT7 agonist 2 | C23H29N3O | 1206846-61-8 | Details |
Carpro-AM1 | C21H18ClN3O | 2499489-76-6 | Details |
hCAIX/XII-IN-4 | C20H16N2O5 | 1119200-33-7 | Details |
Antileishmanial agent-3 | C14H13ClN6O4 | 2755930-28-8 | Details |
Pantothenate kinase-IN-1 | C21H25N5O | 1024168-48-6 | Details |
Product Total: Product Page: | ||||
106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 |